Kala BioKALA
13F holders, Q2 2026 (June 30)14holders
$1.73avg. 13F price*
At the end of Q2 2026, 14 institutions reported holding Kala Bio Inc. (KALA) in their 13F filings. The largest holders were Vanguard Capital Management LLC ($382K), Geode Capital Management, LLC ($251K) and Vanguard Fiduciary Trust Co. ($175K).
- Company
- Kala Bio Inc.
- CUSIP
- 483119301
- Latest filing quarter
- Q2 2026
Total Exit/New Position Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 14 | $1.2M |
| Exits | 0 | $0 |
Ownership 14 holders
| Vanguard Capital Management LLC | 0.00% | New | 220,623 | $382K |
| Geode Capital Management, LLC | 0.00% | New | 145,152 | $251K |
| Vanguard Fiduciary Trust Co. | 0.00% | New | 101,396 | $175K |
| State Street Corp. | 0.00% | New | 88,570 | $153K |
| BlackRock, Inc. | 0.00% | New | 71,542 | $124K |
| Northern Trust Corp. | 0.00% | New | 41,606 | $72K |
| Qube Research & Technologies Ltd | 0.00% | New | 11,073 | $19K |
| Goldman Sachs Group Inc. | 0.00% | New | 10,921 | $19K |
| UBS Group AG | 0.00% | New | 9,057 | $16K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 616 | $1K |
| Barclays PLC | 0.00% | New | 608 | $1K |
| Morgan Stanley | 0.00% | New | 28 | $48 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 10 | $17 |
| International Assets Investment Management, LLC | 0.00% | New | 2 | $4 |
"% of holder's portfolio" is KALA's weight in each manager's 13F, not the share of Kala Bio Inc. the manager owns.